TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹37 Cr | ₹32 Cr | ₹38 Cr | ₹3.10 Cr |
What is the latest Net Current Assets ratio of TRIDENT LIFELINE ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹3.10 Cr |
How is Net Current Assets of TRIDENT LIFELINE Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 16.07 | |
| Mar2024 | ₹32 Cr | -15.81 | |
| Mar2023 | ₹38 Cr | 1,116.93 | |
| Mar2022 | ₹3.10 Cr | - | |
Compare Net Current Assets of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹308.0 Cr | 9.3% | 8.6% | -2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 9.3% |
8.6% |
-2.7% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses